(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ONCOGENIUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

ONCOGENIUS

ST13

US500000097266524

Class

35, 41, 42

Filing

97266524

Registration

7190822

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

10/10/2023

Classification

Registered

Trademark type

Word

Nice classes

35, 41, 42

Filing date

02/14/2022

Registration date

10/10/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/10/2023

Last transaction

10/10/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

03/09/2022

First use in commerce

2020309

Drawing code

4

Owner type

16

Owner location

Bethesda, MD, US

Examiner

CROWLEY, SEAN MICHAEL

Law office

M70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Precision Medicine Group, LLC

Representatives

Donna H. Hartman OLENDERFELDMAN LLP

Technical classification

Nice Classes

Class 35Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Providing business management consulting servicesincluding advice and business strategies for payer and provider access decision making to oncology-based pharmaceutical and life sciences companies in the fields of launch planningaccess strategydata orchestrationpredictive analyticsproduct uptake forecastingpromotional focusmarket adoption; Providing business management consultation services in the fields of promotion opportunity assessmentpromotion effectivenesspayer promotion strategyaccount manager and sales force promotion strategydistribution strategy

Class 41

Providing online non-downloadable electronic publications in the nature of articlespublicationsinformational reports in the field of healthcare business for the healthcare industry

Class 42

Providing online non-downloadable software to utilize payor and provider access landscape information in the nature of articlespublicationsinformational reports in the field of healthcare business for the healthcare industry

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/10/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

10/10/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/06/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/05/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/03/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/31/2023

IUAF

USE AMENDMENT FILED

07/12/2023

EISU

TEAS STATEMENT OF USE RECEIVED

07/12/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/13/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/18/2023

PUBO

PUBLISHED FOR OPPOSITION

04/18/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/29/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/16/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

03/16/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/16/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

03/16/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/16/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/14/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/14/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/14/2022

GNRT

NON-FINAL ACTION E-MAILED

12/14/2022

CNRT

NON-FINAL ACTION WRITTEN

12/14/2022

DOCK

ASSIGNED TO EXAMINER

11/29/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/18/2022

NWAP

NEW APPLICATION ENTERED

02/17/2022

Continuous trademark protection

Get notified about every new filing that threatens ONCOGENIUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.